{
     "PMID": "15145704",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20050118",
     "LR": "20131121",
     "IS": "0014-2999 (Print) 0014-2999 (Linking)",
     "VI": "492",
     "IP": "1",
     "DP": "2004 May 10",
     "TI": "Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice.",
     "PG": "41-8",
     "AB": "We recently demonstrated that mice lacking the gene for substance P (neurokinin 1) receptors (NK1-/-) show improved cortical dialysate serotonin (5-HT) responses to paroxetine [J. Neurosci. 21 (2001) 8188]. To test for changes that may involve the 5-HT transporter (5-HTT) in these mutant mice, in vivo/in vitro studies were performed. Autoradiographic quantification of 5-HTT was performed: [3H]citalopram binding did not reveal any modification of 5-HT binding sites in the dorsal raphe nucleus (DRN) of wild-type NK1+/+ control and mutant NK1-/- mice. These results were further confirmed by 5-HTT mRNA quantification using competitive reverse transcription and polymerase chain reaction (RT-PCR) assay, which showed similar messenger levels in the DRN of both mice genotypes. The functional status of 5-HTT in vivo was tested by using the zero net flux method of quantitative microdialysis in two serotonergic nerve terminal regions, the frontal cortex and ventral hippocampus, of wild-type NK1+/+ and NK1-/- mice. Neither basal extracellular 5-HT levels nor the 5-HT extraction fraction of the probe (Ed an index of 5-HT uptake in vivo) differed between wild-type and mutant mice in the two brain regions studied. These results suggest that no compensatory response to the constitutive deletion of the tachykinin NK1 receptor involving changes in the activity of the selective 5-HT transporter occurred in the DRN, frontal cortex and ventral hippocampus in mice.",
     "FAU": [
          "David, Denis J",
          "Froger, Nicolas",
          "Guiard, Bruno",
          "Przybylski, Cedric",
          "Jego, Gaelle",
          "Boni, Claudette",
          "Hunt, Stephen P",
          "De Felipe, Carmen",
          "Hamon, Michel",
          "Jacquot, Christian",
          "Gardier, Alain M",
          "Lanfumey, Laurence"
     ],
     "AU": [
          "David DJ",
          "Froger N",
          "Guiard B",
          "Przybylski C",
          "Jego G",
          "Boni C",
          "Hunt SP",
          "De Felipe C",
          "Hamon M",
          "Jacquot C",
          "Gardier AM",
          "Lanfumey L"
     ],
     "AD": "Laboratoire de Neuropharmacologie Tour D1, 2eme etage, EA 3544 MJENR, Faculte de Pharmacie IFR75-ISIT Institut de Signalisation et d'Innovation Therapeutique, Universite Paris-Sud, 5 rue J-B. Clement, F92296 Chatenay-Malabry, France.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Comparative Study",
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Netherlands",
     "TA": "Eur J Pharmacol",
     "JT": "European journal of pharmacology",
     "JID": "1254354",
     "RN": [
          "0 (Membrane Glycoproteins)",
          "0 (Membrane Transport Proteins)",
          "0 (Nerve Tissue Proteins)",
          "0 (RNA, Messenger)",
          "0 (Receptors, Neurokinin-1)",
          "0 (Serotonin Plasma Membrane Transport Proteins)",
          "0 (Serotonin Uptake Inhibitors)",
          "0 (Slc6a4 protein, mouse)",
          "0DHU5B8D6V (Citalopram)",
          "333DO1RDJY (Serotonin)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Autoradiography",
          "Citalopram/pharmacology",
          "Extracellular Fluid/metabolism",
          "Frontal Lobe/drug effects/metabolism",
          "Hippocampus/drug effects/metabolism",
          "Membrane Glycoproteins/genetics/*metabolism",
          "Membrane Transport Proteins/genetics/*metabolism",
          "Mice",
          "Mice, Knockout",
          "Microdialysis",
          "Nerve Tissue Proteins/genetics/*metabolism",
          "RNA, Messenger/analysis/metabolism",
          "Raphe Nuclei/drug effects/*metabolism",
          "Receptors, Neurokinin-1/*genetics",
          "Reverse Transcriptase Polymerase Chain Reaction",
          "Serotonin/analysis/*metabolism",
          "Serotonin Plasma Membrane Transport Proteins",
          "Serotonin Uptake Inhibitors/pharmacology"
     ],
     "EDAT": "2004/05/18 05:00",
     "MHDA": "2005/01/19 09:00",
     "CRDT": [
          "2004/05/18 05:00"
     ],
     "PHST": [
          "2003/08/04 00:00 [received]",
          "2004/02/24 00:00 [revised]",
          "2004/03/03 00:00 [accepted]",
          "2004/05/18 05:00 [pubmed]",
          "2005/01/19 09:00 [medline]",
          "2004/05/18 05:00 [entrez]"
     ],
     "AID": [
          "10.1016/j.ejphar.2004.03.016 [doi]",
          "S0014299904002298 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Eur J Pharmacol. 2004 May 10;492(1):41-8. doi: 10.1016/j.ejphar.2004.03.016.",
     "term": "hippocampus"
}